Pfizer (PFE) Risk/Reward Seems Favorable, But Not Enough for Upgrade - BMO

January 31, 2019 12:21 PM
BMO Capital analyst Alex Arfaei said Pfizer's (NYSE: PFE) risk/reward in PFE remains favorable, but given the stock's strong performance ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles